您要查找的是不是：
- Increased urinary albumin excretion was present in all, acute tubular necrosis in five of six, and glomerular sclerosis in two grafts. 所有的大鼠均存在蛋白尿，六分之五的大鼠存在急性小管坏死。
- The frequencies of mesangial proliferation, glomerular nodule lesions, and glomerular sclerosis were higher in DN patients with amylin deposits. 有胰淀素沉积的DN患者肾小球系膜增生、血管小球结节损伤和肾小球硬化发生率较高。
- A renal biopsy showed glomerular sclerosis and collapse secondary to the glomerular and vascular lesions of thrombotic microangiopathy. 病人总共接受了8次的血浆置换术，其临床表现、以及血液检查数据才逐渐稳定。
- By researching preventing and curing glomerular sclerosis,we have found that glomerular sclerosis is Origin xu and Superficiality shi. 通过对中医药防治肾小球硬化的研究发现,肾小球硬化是本虚标实证。
- Conclusion: Irbesartan can up-regulate the renal HGF, strengthen its renotrophic function and retard the development of glomerular sclerosis and tubulointerstitial fibrosis. 结论：厄贝沙坦可以上调肾组织HGF的分泌，加强HGF的肾保护作用，延缓肾小球硬化，减轻肾小管-间质纤维化。
- BackgroundThe GMC proliferation plays an important role in glomerular sclerosis by influencing the ECMs secretion and mechanical injury on the glomerular capillaries. 肾小球系膜细胞(GMC)的增殖通过影响细胞外基质(ECM)的分泌和对肾小球毛细血管的机械损伤而在肾小球硬化过程中发挥着重要作用。
- Glomerular sclerosis (GS) in diabetic nephropa-thy (DN) is developed from lingering diabetes involving the kidney and is attributive to the category of "shenji"in TCM. 糖尿病肾病(DN)肾小球硬化由肾消迁延日久发展而来,提出肾小球硬化的病理改变与中医学积证相类,可归属肾积范畴。
- DD genotype and D allele showed obvious dominance in drug-resistant group and cases performed with renal biopsy,especially those with focal segmental glomerular sclerosis(FSGS). 耐药组和肾活检病例尤其局灶性节段性肾小球硬化 (FSGS)明显显示缺失型 (DD基因型 )和D等位基因占优势 ,临床耐药的肾活检病例也以DD型和D等位基因明显占优势。
- In the pathological sections of model group,focal segmental glomerular sclerosis,dropsy in renal tubular epithelial cells,protein cast in some renal tubules and tubulointerstitial fibrosis could be seen. 病理形态学观察:模型组肾小球呈局灶性节段性硬化,肾小管上皮细胞水肿,部分小管腔内可见蛋白管型,肾间质纤维化;
- Animal model of progressive glomerular sclerosis 八、进行性肾小球硬化模型
- focal segmental glomerular sclerosis (FSGS) 局灶节段性肾小球硬化
- Study of Preventing Progress of Glomerular Sclerosis by Zhi-Shen Mixture 蛭参合剂延缓肾小球硬化进展的实验研究
- Advances in diagnosis and treatment of focal segmental glomerular sclerosis 局灶节段性肾小球硬化诊治的进展
- Compose of Formulation Thought of SHENSHUNING and Analyzing Mechanism for Preventing and Curing Glomerular Sclerosis 肾疏宁的组方思路及防治肾小球硬化的机制分析
- A Rat Model of Membranous Glomerulonephritis With the Formation of Crescent and Glomerular Sclerosis 复制大鼠膜性肾小球肾炎伴新月体形成和肾小球硬化模型的研究
- The relationship between glomerular sclerosis and the change of extracellular matrix 肾小球硬化与系膜基质改变的关系
- Experimental study of the renal protective effects and mechanism of benazepril in young rats with glomerular sclerosis 苯那普利对幼鼠的保肾作用及其部分机制探讨
- General Situation of Research on Treatment and Prevention of Glomerular Sclerosis with Compound Chinese Medicines 中药复方防治肾小球硬化的研究概况
- Influence of valsartan on the expression of monocyte chemoattractant protein-1 in nephridial tissue of glomerular sclerosis rats 缬沙坦对肾小球硬化大鼠肾组织单核细胞趋化蛋白-1表达的影响
- Mechanism Study of Therapy of Dissipating Phlegm, Promoting Blood Flow and Removing Stasis on Treating Glomerular Sclerosis 化痰活血软坚法干预肾小球硬化机理的实验研究
